On Sunday, Health Ministry indicated that almost 20-25 Crore individuals will be vaccinated by double dose of Vaccine by Upcoming July.
Notably, States have already been asked to prepare a list of “priority population groups” to get the vaccine. These would include frontline health workers — doctors from both private and government sectors, paramedics, nurses, ASHA workers, sanitary staff, surveillance officers and all those testing and treating the patients.
On Sunday, Harsh Vardhan was speaking at his weekly social media interaction, Sunday Samvad.
“#WatchNow the 4th Edition of #SundaySamvaad I’m thankful that so many of you are participating actively in this dialogue and helping to create mass awareness on important issues,” Harsh Vardhan tweeted.
“The Centre is working on plans for building capacities in human resources, training, supervision etc. on a massive scale and roughly estimates to receive and utilise 400-500 million doses covering approximately 20-25 crore people by July 2021,” said Union Health Minister HarshVardhan, adding “All this is under various stages of finalisation.”
While talking about Government’s strategies to further tackle with CoronaVirus he said, “Our govt is working round the clock to ensure that there is a fair and equitable distribution of vaccines, once they are ready. Our utmost priority is how to ensure vaccine for each and everybody in the country,”
Currently, There are three prominent vaccine candidates being tested in India and only one CoviShield has reached phase-3 trials. Notably, Covishield, developed by Oxford University and pharma major AstraZeneca, is being tested in India by the Serum Institute of India (SII), Pune. Though not confirmed, at least 50 million doses of these so far are likely to be available for India at about ₹250 per vaccination. The other two candidates being tested by Zydus Cadilla and Bharat Biotech are in phase-2 trials.
Earlier, Harsh Vardhan had said the first vaccine for COVID-19 is likely to be available in the first quarter of 2021. “There are at least three viable such vaccine candidates that are in the phase of clinical trials right now in the country. We are hopeful that within the first quarter of 2021 it will be available,” Vardhan had said
“Even if we have multiple vaccines available, they will all be safe and will elicit the requisite immune response against novel coronavirus,” he added.
“People tire out when they have to constantly take precautions. Some of them also give up taking precautions for various reasons. My message to everyone is that we must all diligently take precautions,” Dr Vardhan said.
Moreover, India’s Covid tally surges past 66-lakh mark with a spike of 74,442 new cases & 903 deaths reported in last 24 hours. The total case tally stands at 66,23,816 including 9,34,427 active cases.